NEW YORK--(BUSINESS WIRE)--
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, reminds investors that it has filed a class action lawsuit against Teligent, Inc. (“Teligent” or the “Company”) (TLGT) and one of its executives for alleged violations of federal securities laws. If you purchased Teligent common stock between May 2, 2017 and November 7, 2017, you are encouraged to contact a Scott+Scott attorney at (646) 992-4756 for more information. The lead plaintiff deadline is June 14, 2019.
The complaint alleges that Teligent, which researches, develops, produces, supplies, and sells generic pharmaceutical products, and its President and Chief Executive Officer, Jason Grenfell-Gardner (“Grenfell-Gardner”), made false and/or misleading statements regarding, and/or failed to disclose, product non-conformities in research and development and non-compliance with applicable regulations.
On November 6, 2017, Teligent disclosed disappointing third quarter 2017 earnings, which Grenfell-Gardner attributed to FDA-approval delays and competition. On this news, Teligent’s share price fell $2.29 from $5.25 on November 6, 2017 to close at $2.96 on November 7, 2017.
What You Can Do
If you purchased Teligent common stock between May 2, 2017 and November 7, 2017, inclusive, or if you have questions about this notice or your legal rights, please contact attorney Jeffrey Jacobson at (646) 992-4756, or via email at firstname.lastname@example.org, or visit the Teligent page on our website at https://scott-scott.com/case/teligent-inc/. The lead plaintiff deadline is June 14, 2019.
About Scott+Scott Attorneys at Law LLP
Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Amsterdam, Connecticut, California, and Ohio.